Indian Pharmacopoeia Commission named WHO-SEARN Regional Centre of Excellence in Pharmacovigilance
Key facts
- The Indian Pharmacopoeia Commission became a WHO-SEARN Regional Centre of Excellence in Pharmacovigilance.
- It was also named a Technical Centre in Quality.
- The news came at SEARN's 10th anniversary meeting in Kathmandu on 4-5 August 2026.
- SEARN is the WHO South-East Asia Regulatory Network, set up in 2016.
Why it matters
[Data] Pharmacovigilance means tracking the side effects of medicines. The IPC runs India's Pharmacovigilance Programme. It works under the Health Ministry.